MENS - Jyong Biotech Limited Net earnings per share (EPS TTM)

Symbol and logo of brand jyongbio.com (MENS)

The TTM earnings per share chart provided by the GURU.Markets platform demonstrates how AI is accelerating the development of men's health products. High certification and patent costs create a robust defensive moat for Jyong Biotech Ltd (MENS), while the -0.06 metric determines the status of the yield parameter. However, the lack of stable sales and stringent FDA requirements for botanical drugs create significant capital intensity risks.

MENS (Jyong Biotech Ltd) Net earnings per one share for the last twelve months history from 06/18/2025 to 11/17/2026

Jyong Biotech Ltd (MENS) - metric breakdowns and financial figures

- share price and expert price forecast:
Basic company analysis:MENS - Jyong Bio
Mass-produced product of Jyong Bio

Analyzing EPS TTM is critical for constructing a defensive portfolio, as it measures the annual earnings per share and isolates financial results from the impact of share issuance volume. In the case of Jyong Biotech Ltd (MENS), this TTM net income per share slice reflects the efficiency of AI-driven drug synthesis against the backdrop of high costs for mandatory clinical trials.

Main competitors

Haleon - Net earnings per share (EPS TTM)|Kenvue - Earnings per share for the last four quarters|VRNA: Net earnings per share (EPS TTM)|Ligand Pharma - Earnings per share for the trailing year|AMRX (Amneal Pharmaceuticals, Inc.) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months perrigo.com PRGO|Earnings per share for the last twelve months Alvotech SA (ALVO)|LQDA (Liquidia Corp) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) GLPG (Galapagos N.V.)|Net earnings per share (EPS TTM) ANI Pharmaceuticals Corp ANIP|Afrezza - Net earnings per share (EPS TTM)|amphastar.com (AMPH) - Net earnings per share for the last 12 months|PCRX: Net earnings per share (EPS TTM)|SPRY - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Theravance|Net earnings per one share for the last twelve months Aquestive Corp AQST|Net earnings per share (EPS TTM) SCPH|TECX - Net earnings per one share for the last twelve months|Tonix Pharmaceuticals Holding Corp. - Net earnings per share for the last 12 months|Earnings per share for the trailing year SXTC|Eupraxia Pharmaceuticals, Inc. - Net earnings per share (EPS TTM)|BHST: Earnings per share for the last twelve months|invizyne.com (EXOZ) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months ORMP (Oramed)|ENTX (Entera Bio) - Net earnings per share (EPS TTM)|HYFT: Earnings per share for the trailing year|Net earnings per share (EPS TTM) ABVC|Cumberland Pharmaceuticals - Earnings per share for the last 12 months|Earnings per share for the last twelve months Quantum BioPharma Ltd. QNTM|FGEN: Earnings per share for the last 12 months|TELO - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Rani Therapeutics Holdings|SNYR: Net earnings per share (EPS TTM)|Earnings per one share for the last 12 months RLYB (Rallybio Corp.)|LEXX (Lexaria Bioscience Corp.) - Net earnings per share (EPS TTM)|pulmatrix.com (PULM) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Pheton (PTHL)|Net earnings per share for the last four quarters Aptorum Group Ltd|Net earnings per share (EPS TTM) LYRA (Lyra Therapeutics Inc)|Impact BioMedical - Earnings per share for the last twelve months|TNF Pharmaceuticals - Net earnings per share (EPS TTM)|YCBD - Net earnings per share (EPS TTM)|PRFX: Net earnings per share (EPS TTM)|CYTO: Earnings per share for the last four quarters|LIPO (Lipella Pharma) - Net earnings per share (EPS TTM)|OPTN: Earnings per share for the trailing year|Net earnings per share (EPS TTM) PIRS|PROC (procapsgroup.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months Petros Pharmaceuticals, Inc. PTPI|Qilian International Holding - Earnings per share for the last twelve months|SLRN - Earnings per share for the last twelve months|Earnings per one share for the last 12 months TFFP